Related Experiment Video
Updated: May 25, 2025
13:26
Determination of Protein-ligand Interactions Using Differential Scanning Fluorimetry
Published on: September 13, 2014
61.5K
Determining Ligand Binding and Specificity Within the β2-Integrin Family with a Novel Assay Platform
Carla Johanna Sommer-Plüss1, Céline Leiggener1, Elira Nikci1
1Molecular Pharmacy Research Group, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
Biomolecules
|February 26, 2025
Summary
This study presents a validated assay platform for studying beta-2 integrins (β₂-integrins) and their ligands, crucial for immune responses. The platform enables efficient screening of potential drug modulators for various diseases.
Area of Science:
- Immunology
- Molecular Biology
- Drug Discovery
Background:
- Beta-2 integrins (β₂-integrins) are vital for immune cell function, making them attractive drug targets.
- Therapeutic development is hindered by ligand promiscuity and incomplete understanding of disease mechanisms.
- A lack of validated assay systems limits research into β₂-integrin function and modulation.
Purpose of the Study:
- To develop a uniform and validated assay platform for β₂-integrin family studies.
- To facilitate molecular and functional investigations of β₂-integrins and their ligands.
- To enable high-throughput screening of potential therapeutic modulators.
Main Methods:
- Recombinant expression of major ligand-binding domains (αI) of all four β₂-integrins in different affinity states.
- Optimization of expression and purification for high yield and purity.
- Surface Plasmon Resonance (SPR) for direct binding studies and bead-based/cell-based adhesion assays.
Main Results:
- Successfully produced high-yield, high-purity recombinant αI domains for all four β₂-integrins.
- SPR confirmed expected activity and selectivity profiles, validating the assay platform.
- Characterized ligand binding, including novel insights into CD11d, and demonstrated platform utility with simvastatin.
Conclusions:
- The developed platform provides a robust system for studying β₂-integrin-ligand interactions.
- Recombinant αI domains are suitable for initial screening and interaction studies.
- Further validation with full integrins is recommended for drug development.
Related Concept Videos
02:40Ligand Binding Sites
12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
02:18The Equilibrium Binding Constant and Binding Strength
12.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.8K
00:49Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
01:49Conserved Binding Sites
4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
01:25Dose-Response Relationship: Selectivity and Specificity
6.4K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.4K
01:22Protein-Drug Binding: Determination Methods
106
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
106